| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |